| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |